Nisa Investment Advisors, LLC Fulcrum Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $29.3 Billion
- Q4 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 3,602 shares of FULC stock, worth $31,229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,602
Previous 4,281
15.86%
Holding current value
$31,229
Previous $37,000
16.22%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding FULC
# of Institutions
137Shares Held
56.5MCall Options Held
176KPut Options Held
13.5K-
Ra Capital Management, L.P. Boston, MA10.2MShares$88.7 Million1.53% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.38MShares$46.7 Million1.41% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$45.5 Million5.13% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$41.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.67MShares$40.5 Million1.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $451M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...